GSK commits $30 billion to US R&D and factory expansion

GSK announced it will invest $30 billion in the United States over the next five years, including a new factory in Pennsylvania for cancer drugs. The investment is expected to create thousands of jobs.

“Drugmaker GSK said Wednesday it would invest $30 billion in the United States over the next five years, including a new factory in Pennsylvania for cancer drugs.”reuters.com

• 1 source
• reuters.comGSK commits $30 billion to US research and development, factory expansion, as Trump visits UK | ReutersMaggie FickSep 16, 2025

Summarized from public sources; check the original articles before acting on it.